IP Library › Granted Patent US 7,767,829
Granted Patent B2
US 7,767,829 · App. 11/379,596 · Granted Aug 3, 2010

Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents

Assignee: GE Healthcare UK Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,767,829
App. No.
11/379,596
Granted
Aug 3, 2010
Kind
B2
Abstract

Disclosed are cyanine dyes that are useful for labelling and detecting biological and other materials. The dyes are of formula (I): in which at least one of groups R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 R 11 , R 12 , R 13 and R 14 is -L-M or -L-P, where L is a linking group, M is a target bonding group and P is a conjugated component, and at least one of groups R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 comprises fluorine. The use of cyanine dyes substituted by fluorine and having additional substitution with three or more sulphonic acid groups for labelling biological target molecules results in a labelled product in which there is reduced dye-dye aggregation and improved photostability, compared with cyanine dyes having no such substitutions. The dyes of the present invention are particularly useful in assays involving fluorescence detection where continual or repeated excitation is a requirement, for example in kinetic studies, or in microarray analyses where microarray slides may need to be reanalysed over a period of days.

Claims (71)

1. A compound selected from:

wherein:

at least one of groups R 1 , R 2 , R 11 , R 12 , R 13 and R 14 is -L-M or -L-P, where L is a linking group having the formula:

—(CHR′) p -Q-(CHR′) r —

where Q is selected from: —CHR′—, —NR′—, —O—, —S—, —C(O)—NR′— and —C(O)—O—,

where R′ is hydrogen or C 1 -C 4 alkyl; p is 0-5 and r is 1-5;

M is a target bonding group; and

P is a conjugated component;

when any of groups R 1 , R 2 , R 11 , R 12 , R 13 and R 14 is not -L-M or -L-P, said remaining groups R 1 , R 2 , R 11 , R 12 , R 13 and R 14 are selected independently from C 1 -C 6 alkyl, and —(CH 2 ) k —SO 3 H, where k is an integer from 1 to 10;

at least one of groups R 3 , R 4 , R 5 and R 6 and/or groups R 7 , R 8 , R 9 and R 10 are perfluoro C 1 -C 4 alkyl and any remaining groups R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are selected from H or F;

groups R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 and R 23 when present are selected independently from hydrogen, —SO 2 —CF 3 and —(CF 2 ) m —F, where m is 0 or an integer from 1 to 4; and

n is an integer from 1 to 3.

2. The compound of claim 1 , wherein:

at least one of groups R 1 and R 2 is -L-M or -L-P and any remaining group R 1 or R 2 is selected from C 1 -C 6 alkyl and (CH 2 ) k —SO 3 H;

at least one of groups R 11 , R 12 , R 13 and R 14 is —(CH 2 ) k —SO 3 H and any remaining groups R 11 , R 12 , R 13 and R 14 are C 1 -C 6 alkyl.

3. The compound of claim 1 , wherein remaining group R 1 or R 2 is —(CH 2 ) k —SO 3 H.

4. The compound of claim 1 , wherein at least two of R 11 , R 12 , R 13 and R 14 are —(CH 2 ) k —SO 3 H.

5. The compound of claim 4 , wherein one of groups R 11 and R 12 and one of groups R 13 and R 14 is —(CH 2 ) k —SO 3 H; and remaining groups R 11 , R 12 , R 13 or R 14 are C 1 -C 6 alkyl.

6. The compound of claim 1 , wherein:

at least one of groups R 11 , R 12 , R 13 and R 14 is -L-M or -L-P and any remaining groups R 11 , R 12 , R 13 and R 14 are selected from C 1 -C 6 alkyl, and —(CH 2 ) k —SO 3 H;

at least one of groups R 1 and R 2 is —(CH 2 ) k —SO 3 H and any remaining group R 1 or R 2 is C 1 -C 6 alkyl.

7. The compound of claim 6 , wherein R 1 and R 2 are —(CH 2 ) k —SO 3 H.

8. The compound of claim 1 , wherein —(CH 2 ) k —SO 3 H is selected from —(CH 2 ) 3 —SO 3 H and —(CH 2 ) 4 —SO 3 H.

9. The compound of claim 1 , wherein Q is selected from: —CHR′— and —C(O)—NH—.

10. The compound of claim 1 , wherein Q is —CHR′— and R′ is hydrogen.

11. The compound of claim 1 , wherein -L-M or -L-P comprise a carboxypentyl group.

12. The compound of claim 1 , wherein not more than two of the R 3 , R 4 , R 5 and R 6 positions and/or the R 7 , R 8 , R 9 and R 10 positions are substituted by perfluoro C 1 -C 4 alkyl.

13. The compound of claim 1 , wherein said perfluoro C 1 -C 4 alkyl is trifluoromethyl.

14. The compound of claim 1 , wherein said target bonding group M comprises a reactive group for reaction with a functional group on a target material, or a functional group for reaction with a reactive group on a target material.

15. The compound of claim 14 , wherein said reactive group is selected from the group consisting of succinimidyl ester, sulpho-succinimidyl ester, 4-sulfo-2,3,5,6-tetrafluorophenol (STP) ester, isothiocyanate, maleimide, haloacetamide, acid halide, hydrazide, vinylsulphone, dichlorotriazine and phosphoramidite.

16. The compound of claim 14 , wherein said functional group is selected from the group consisting of hydroxy, amino, sulphydryl, imidazole, carbonyl including aldehyde and ketone, carboxylic acid and thiophosphate.

17. The compound of claim 1 , wherein said target bonding group M comprises an affinity tag.

18. The compound of claim 1 , wherein P is selected from the group consisting of antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, microbial materials, drugs, hormones, cells, cell membranes and toxins.

19. A method of labelling a component comprising:

a) contacting said component with a compound of claim 1 ; and

b) reacting said compound with said component such that said compound labels said component.

20. The method of claim 19 , wherein said component is selected from the group consisting of antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, microbial materials, drugs, hormones, cells, cell membranes, toxins, polymer particles, and glass beads.

21. A compound selected from:

wherein:

at least one of groups R 1 , R 2 , R 11 , R 12 , R 13 and R 14 is -L-M or -L-P, where L is a linking group having the formula:

—(CHR′) p -Q-(CHR′) r —

where Q is selected from: —CHR′—, —NR′—, —O—, —S—, —C(O)—NR′— and —C(O)—O—,

where R′ is hydrogen or C 1 -C 4 alkyl; p is 0-5 and r is 1-5;

M is a target bonding group; and

P is a conjugated component;

when any of groups R 1 , R 2 , R 11 , R 12 , R 13 and R 14 is not -L-M or -L-P, said remaining groups R 1 , R 2 , R 11 , R 12 , R 13 and R 14 are selected independently from C 1 -C 6 alkyl, and (CH 2 ) k —SO 3 H, where k is an integer from 1 to 10;

at least one of groups R 3 , R 4 , R 5 and R 6 and/or groups R 7 , R 8 , R 9 and R 10 is —SO 2 —CF 3 and any remaining groups R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are selected from H or F; groups R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , and R 23 when present are selected independently from hydrogen, —SO 2 —CF 3 and —(CF 2 ) m —F, where m is 0 or an integer from 1 to 4; and

n is an integer from 1 to 3.

22. The compound of claim 21 , wherein:

at least one of groups R 1 and R 2 is -L-M or -L-P and any remaining group R 1 or R 2 is selected from C 1 -C 6 alkyl and —(CH 2 ) k —SO 3 H;

at least one of groups R 11 , R 12 , R 13 and R 14 is —(CH 2 ) k —SO 3 H and any remaining groups R 11 , R 12 , R 13 and R 14 are C 1 -C 6 alkyl.

23. The compound of claim 21 , wherein remaining group R 1 or R 2 is —(CH 2 ) k —SO 3 H.

24. The compound of claim 21 , wherein at least two of R 11 , R 12 , R 13 and R 14 are —(CH 2 ) k —SO 3 H.

25. The compound of claim 24 , wherein one of groups R 11 and R 12 and one of groups R 13 and R 14 is —(CH 2 ) k —SO 3 H; and remaining groups R 11 , R 12 , R 13 or R 14 are C 1 -C 6 alkyl.

26. The compound of claim 21 , wherein:

at least one of groups R 11 , R 12 , R 13 and R 14 is -L-M or -L-P and any remaining groups R 11 , R 12 , R 13 and R 14 are selected from C 1 -C 6 alkyl, and —(CH 2 ) k —SO 3 H;

at least one of groups R 1 and R 2 is —(CH 2 ) k —SO 3 H and any remaining group R 1 or R 2 is C 1 -C 6 alkyl.

27. The compound of claim 26 , wherein R 1 and R 2 are —(CH 2 ) k —SO 3 H.

28. The compound of claim 21 , wherein —(CH 2 ) k —SO 3 H is selected from —(CH 2 ) 3 —SO 3 H and —(CH 2 ) 4 —SO 3 H.

29. The compound of claim 21 , wherein Q is selected from: —CHR′— and —C(O)—NH—.

30. The compound of claim 21 , wherein Q is —CHR′— and R′ is hydrogen.

31. The compound of claim 21 , wherein -L-M or -L-P comprise a carboxypentyl group.

32. The compound of claim 21 , wherein said target bonding group M comprises a reactive group for reaction with a functional group on a target material, or a functional group for reaction with a reactive group on a target material.

33. The compound of claim 32 , wherein said reactive group is selected from the group consisting of succinimidyl ester, sulpho-succinimidyl ester, 4-sulfo-2,3,5,6-tetrafluorophenol (STP) ester, isothiocyanate, maleimide, haloacetamide, acid halide, hydrazide, vinylsulphone, dichlorotriazine and phosphoramidite.

34. The compound of claim 32 , wherein said functional group is selected from the group consisting of hydroxy, amino, sulphydryl, imidazole, carbonyl including aldehyde and ketone, carboxylic acid and thiophosphate.

35. The compound of claim 21 , wherein said target bonding group M comprises an affinity tag.

36. The compound of claim 21 , wherein P is selected from the group consisting of antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, microbial materials, drugs, hormones, cells, cell membranes and toxins.

37. A method of labelling a component comprising:

a) contacting said component with a compound of claim 21 ; and

b) reacting said compound with said component such that said compound labels said component.

38. The method of claim 37 , wherein said component is selected from the group consisting of antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl, carboxylic acid and thiophosphate groups, microbial materials, drugs, hormones, cells, cell membranes, toxins, polymer particles, and glass beads.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2020
From: GE HEALTHCARE EUROPE GMBH
To: GLOBAL LIFE SCIENCES SOLUTIONS GERMANY GMBH
Reel/Frame 053497/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2020
From: GE HEALTHCARE UK LIMITED
To: GE HEALTHCARE EUROPE GMBH
Reel/Frame 053487/0672 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2006
From: GARDNER, NICHOLAS JOHN; LAUGHTON, PETER GORDON; COOPER, MICHAEL EDWARD
To: GE HEALTHCARE UK LIMITED
Reel/Frame 017856/0123 →
Priority Claims (2)
GB 0508082.5 · Apr 22, 2005 · national
GB 0517656.5 · Aug 31, 2005 · national
Continuity (1)
Related Publication 20060239922A1 · Oct 26, 2006